These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19906157)

  • 1. Purification and characterization of a new recombinant factor VIII (N8).
    Thim L; Vandahl B; Karlsson J; Klausen NK; Pedersen J; Krogh TN; Kjalke M; Petersen JM; Johnsen LB; Bolt G; Nørby PL; Steenstrup TD
    Haemophilia; 2010 Mar; 16(2):349-59. PubMed ID: 19906157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a recombinant antihaemophilia-A factor (factor VIII-delta II) by matrix-assisted laser desorption/ionization mass spectrometry.
    Bihoreau N; Veillon JF; Ramon C; Scohyers JM; Schmitter JM
    Rapid Commun Mass Spectrom; 1995; 9(15):1584-8. PubMed ID: 8652881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII.
    Schmidbauer S; Witzel R; Robbel L; Sebastian P; Grammel N; Metzner HJ; Schulte S
    Thromb Res; 2015 Aug; 136(2):388-95. PubMed ID: 26037285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII.
    Pittman DD; Alderman EM; Tomkinson KN; Wang JH; Giles AR; Kaufman RJ
    Blood; 1993 Jun; 81(11):2925-35. PubMed ID: 8499631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid residues 721-729 are required for full factor VIII activity.
    Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
    Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of recombinant blood coagulation factor VIII (FVIII) heavy and light chains and reconstitution of active form of FVIII.
    Oh SH; Lee MY; Song DW
    Exp Mol Med; 1999 Jun; 31(2):95-100. PubMed ID: 10410309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional requirement of Cu(I) and its ligands within coagulation factor VIII.
    Tagliavacca L; Moon N; Dunham WR; Kaufman RJ
    J Biol Chem; 1997 Oct; 272(43):27428-34. PubMed ID: 9341195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of site-specific N-glycosylation of recombinant human factor VIII by reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry.
    Medzihradszky KF; Besman MJ; Burlingame AL
    Anal Chem; 1997 Oct; 69(19):3986-94. PubMed ID: 9322435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis.
    Mosesson MW; Fass DN; Lollar P; DiOrio JP; Parker CG; Knutson GJ; Hainfeld JF; Wall JS
    J Clin Invest; 1990 Jun; 85(6):1983-90. PubMed ID: 2112158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in the tyrosine sulfation of Chinese hamster ovary cell produced recombinant FVIII.
    Mikkelsen J; Thomsen J; Ezban M
    Biochemistry; 1991 Feb; 30(6):1533-7. PubMed ID: 1899619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII delta II.
    Krishnan S; Kolbe HV; Lepage P; Faure T; Sauerwald R; de la Salle H; Muller C; Bihoreau N; Paolantonacci P; Roitsch C
    Eur J Biochem; 1991 Feb; 195(3):637-44. PubMed ID: 1900236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models.
    Stennicke HR; Kjalke M; Karpf DM; Balling KW; Johansen PB; Elm T; Øvlisen K; Möller F; Holmberg HL; Gudme CN; Persson E; Hilden I; Pelzer H; Rahbek-Nielsen H; Jespersgaard C; Bogsnes A; Pedersen AA; Kristensen AK; Peschke B; Kappers W; Rode F; Thim L; Tranholm M; Ezban M; Olsen EH; Bjørn SE
    Blood; 2013 Mar; 121(11):2108-16. PubMed ID: 23335368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog.
    Lollar P; Parker ET
    J Biol Chem; 1991 Jul; 266(19):12481-6. PubMed ID: 1905722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-atom identification in the active and inactive forms of plasma-derived FVIII and recombinant FVIII-delta II.
    Bihoreau N; Pin S; de Kersabiec AM; Vidot F; Fontaine-Aupart MP
    Eur J Biochem; 1994 May; 222(1):41-8. PubMed ID: 8200351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterization of a codon-optimized blood coagulation factor VIII.
    Shestopal SA; Hao JJ; Karnaukhova E; Liang Y; Ovanesov MV; Lin M; Kurasawa JH; Lee TK; Mcvey JH; Sarafanov AG
    J Thromb Haemost; 2017 Apr; 15(4):709-720. PubMed ID: 28109042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular design and downstream processing of turoctocog alfa (NovoEight), a B-domain truncated factor VIII molecule.
    Ahmadian H; Hansen EB; Faber JH; Sejergaard L; Karlsson J; Bolt G; Hansen JJ; Thim L
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):568-75. PubMed ID: 26761578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII.
    Pittman DD; Wang JH; Kaufman RJ
    Biochemistry; 1992 Apr; 31(13):3315-25. PubMed ID: 1554716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining 'full-length' recombinant factor VIII: a comparative structural analysis.
    Jankowski MA; Patel H; Rouse JC; Marzilli LA; Weston SB; Sharpe PJ
    Haemophilia; 2007 Jan; 13(1):30-7. PubMed ID: 17212722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma-derived clotting factor VIII: heterogeneity evaluation in the quest for potential inhibitory-antibody stimulating factors.
    D'Amici GM; Blasi B; D'Alessandro A; Vaglio S; Zolla L
    Electrophoresis; 2011 Nov; 32(21):2941-50. PubMed ID: 21997645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of factor VIII 372-Cys: a hypofunctional cofactor from a patient with moderately severe hemophilia A.
    O'Brien DP; Pattinson JK; Tuddenham EG
    Blood; 1990 Apr; 75(8):1664-72. PubMed ID: 2109644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.